| TAVR N = 2101 | SAVR N = 2044 | p-value |
Age mean ± SD | 81.7 ± 6.7 | 81.8 ± 6.6 | 0.63 |
Male % | 53.6 | 54.3 | 0.67 |
NYHA III or IV % | 79.8 [1889] | 79.4 [1866] | 0.79 |
Diabetes % | 35.1 [1541] | 35.6 [1515] | 0.80 |
Creatinine > 2 mg/dL | 5.2 | 4.8 | 0.60 |
Peripheral vascular disease | 29.0 | 31.5 | 0.09 |
Cerebrovascular disease | 30.0 [1750] | 29.0 [1731] | 0.54 |
COPD/Chronic lung disease | 35.2 [1889] | 34.0 [1866] | 0.46 |
Permanent pacemaker | 15.0 [1889] | 15.1 [1866] | 0.97 |
Atrial fibrillation/flutter | 34.7 [1889] | 38.1 [1866] | 0.03 |
Coronary artery disease | 67.9 [1618] | 66.1 [1596] | 0.29 |
Prior CABG | 28.7 [1750] | 30.5 [1731] | 0.26 |
STS Score mean ± SD | 7.0 ± 3.6 [1889] | 7.0 ± 3.6 [1886] | >0.99 |
LVEF (%) | 57.1 ± 11.5 [1618] | 56.3 ± 12.0 [1596] | 0.05 |